Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC007941 | Panoply™ Human KCNE2 Knockdown Stable Cell Line | Inquiry |
| CSC-SC007941 | Panoply™ Human KCNE2 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD08397Z | Human KCNE2 adenoviral particles | Inquiry |
| LV15939L | human KCNE2 (NM_172201) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH322939 | shRNA set against Human KCNE2 (NM_172201.1) | Inquiry |
| SHH322943 | shRNA set against Mouse KCNE2 (NM_134110.3) | Inquiry |
| SHH322947 | shRNA set against Rat KCNE2 (NM_133603.2) | Inquiry |
| SHL188992 | shRNA set against Rat Kcne2(NM_133603.2) | Inquiry |
| SHL189028 | shRNA set against Human KCNE2(NM_172201.1) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFG010461 | Human KCNE2 cDNA Clone(NM_172201.1) | Inquiry |
| CDFR014116 | Rat Kcne2 cDNA Clone(NM_133603.2) | Inquiry |
| MiUTR1H-05105 | KCNE2 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-02800 | KCNE2 miRNA 3'UTR clone | Inquiry |
| CDCB181118 | Rabbit KCNE2 ORF clone (XM_008274920.1) | Inquiry |
| CDCL122891 | Human KCNE2 ORF clone (NM_172201.1) | Inquiry |
| CDCR381171 | Rat Kcne2 ORF Clone(NM_133603.2) | Inquiry |
Recent Research
KCNE2, also called MinK-related peptide MiRP1, is a member of the small auxiliary subunits of voltage-gated cation channels encoded by KCNE family gene, members of which each encode a single-pass membrane protein. KCNE2 is expressed in human heart but is also particularly enriched in certain secretory epithelia, including gastric parietal cells. KCNE2 modulates cardiac Kv alpha subunits human eag-related gene (HERG) and KCNQ1 in vitro. In parietal cells, KCNE2 forms complexes with the KCNQ1 voltage-gated potassium channel pore-forming (α) subunit, resulting in a remarkable transformation. KCNE proteins can regulate most aspects of Kv channel biology, from channel biogenesis itself through to gating, selectivity and conductivity of functional channels at the membrane, and even channel internalization from the membrane.
It has been found that KCNE2 deletion impairs hyperpolarization-activated, cyclic nucleotide-gated (HCN) channel function in cortical-thalamic relay neurons, suggesting the possibility of HCN-KCNE2 complexes in mammalian brain. In addition, KCNE2 can also reportedly regulate the cardiac voltage-gated calcium channel, Cav1.2, forming complexes with reduced activity compared to channels lacking KCNE2, possibly mediated through the Cav1.2 N-terminal inhibitory module. KCNE2 can also regulate Kv channels that are expressed in the brain. It has been shown that, KCNE2 deletion in mice causes a multisystem syndrome that adversely impacts the heart, generating both electrical disturbances and creating an ischaemic substrate.
Furthermore, KCNE2 is important in maintaining the cardiac electrical stability because mutations or a polymorphism in KCNE2 have been linked to long QT syndrome (LQT6) and familial atrial fibrillation/short QT syndrome. Targeted deletion of KCNE2 impairs ventricular repolarization and predisposes the heart to arrhythmia. Among the KCNE subunits, KCNE2 has the most promiscuity of function which can coassemble with multiple α-subunits of voltage-dependent cation channels and modulate their gating, conductance and pharmacology. Heretofore, heterologously expressed KCNE2 has been demonstrated to regulate hERG, KCNQ1–3, Kv3.1, Kv3.2, Kv4.2, Kv4.3, Kv1.5, and HCN (pacemaker) cardiac ion channel α subunits.
References: